| Joplin Prosthetics And Orthotics | |
| 2312 Connecticut, Joplin, Missouri 64804 | |
| (417) 659-8488 |
| Name | Joplin Prosthetics And Orthotics |
|---|---|
| Organization Name | Kessler- Heasley Artificial Limb Co |
| Location | 2312 Connecticut, Joplin, Missouri 64804 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (417) 659-8488 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalized for or dying from COVID-19 due to their cancer, a new study shows.
In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis. In doing so, the findings upend the standing of a long-presumed marker for multiple fibrotic diseases and reveal the existence of a previously unknown kind of inflammatory white blood cell.
Immunotherapy with the anti-PD-1 antibody pembrolizumab (Keytruda) was effective in one out of four patients with recurrent or metastatic head and neck cancer, according to results presented at the 2015 meeting of the American Society for Clinical Oncology.
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
› Verified 6 days ago
| NPI Number | 1154734317 |
| Organization Name | KESSLER-HEASLEY ARTIFICIAL LIMB CO. |
| Doing Business As | JOPLIN PROSTHETICS AND ORTHOTICS |
| Type | Prosthetic/Orthotic Supplier |
| Address | 2312 Connectcut, Joplin, MO 64804 |
| Phone Number | 417-659-8488 |
News Archive
Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalized for or dying from COVID-19 due to their cancer, a new study shows.
In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis. In doing so, the findings upend the standing of a long-presumed marker for multiple fibrotic diseases and reveal the existence of a previously unknown kind of inflammatory white blood cell.
Immunotherapy with the anti-PD-1 antibody pembrolizumab (Keytruda) was effective in one out of four patients with recurrent or metastatic head and neck cancer, according to results presented at the 2015 meeting of the American Society for Clinical Oncology.
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
› Verified 6 days ago
News Archive
Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalized for or dying from COVID-19 due to their cancer, a new study shows.
In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis. In doing so, the findings upend the standing of a long-presumed marker for multiple fibrotic diseases and reveal the existence of a previously unknown kind of inflammatory white blood cell.
Immunotherapy with the anti-PD-1 antibody pembrolizumab (Keytruda) was effective in one out of four patients with recurrent or metastatic head and neck cancer, according to results presented at the 2015 meeting of the American Society for Clinical Oncology.
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
› Verified 6 days ago
Adapthealth - Missouri Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7931 E 32nd St, Joplin, Missouri 64804 Phone: (844) 740-4093 | |
Advanced Orthotics And Prosthetics Type: Prosthetic/Orthotic Supplier Location: 2530s Maiden Ln, Joplin, Missouri 64804 Phone: (417) 627-0999 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2024s Maiden Ln 1, Joplin, Missouri 64804 Phone: (417) 782-6212 | |
Brothers Bezold & Associates Type: Medicare Supplier Location: 2013 S Joplin Ave, Joplin, Missouri 64804 Phone: (417) 624-5005 | |
Health Essentials Type: DME Supplier - Parenteral & Enteral Nutrition Location: 1130 E 32nd St, Joplin, Missouri 64804 Phone: (417) 623-0166 |